|
US3657744A
(en)
|
1970-05-08 |
1972-04-25 |
Univ Minnesota |
Method for fixing prosthetic implants in a living body
|
|
US4733665C2
(en)
|
1985-11-07 |
2002-01-29 |
Expandable Grafts Partnership |
Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
JPS62135832A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62135830A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料及びその処理方法
|
|
JPS62135834A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62135835A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62136651A
(ja)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料の処理方法
|
|
JPS62136654A
(ja)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JPS62136650A
(ja)
|
1985-12-11 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料及びその処理方法
|
|
US5350395A
(en)
|
1986-04-15 |
1994-09-27 |
Yock Paul G |
Angioplasty apparatus facilitating rapid exchanges
|
|
US5061273A
(en)
|
1989-06-01 |
1991-10-29 |
Yock Paul G |
Angioplasty apparatus facilitating rapid exchanges
|
|
US5040548A
(en)
|
1989-06-01 |
1991-08-20 |
Yock Paul G |
Angioplasty mehtod
|
|
US4748982A
(en)
|
1987-01-06 |
1988-06-07 |
Advanced Cardiovascular Systems, Inc. |
Reinforced balloon dilatation catheter with slitted exchange sleeve and method
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
GB8808433D0
(en)
|
1988-04-11 |
1988-05-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA1322628C
(en)
|
1988-10-04 |
1993-10-05 |
Richard A. Schatz |
Expandable intraluminal graft
|
|
US6344053B1
(en)
|
1993-12-22 |
2002-02-05 |
Medtronic Ave, Inc. |
Endovascular support device and method
|
|
US5674278A
(en)
|
1989-08-24 |
1997-10-07 |
Arterial Vascular Engineering, Inc. |
Endovascular support device
|
|
US5292331A
(en)
|
1989-08-24 |
1994-03-08 |
Applied Vascular Engineering, Inc. |
Endovascular support device
|
|
US5041453A
(en)
|
1990-05-30 |
1991-08-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4
|
|
US6063930A
(en)
|
1996-04-03 |
2000-05-16 |
Merck & Co., Inc. |
Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
|
|
EP0891334A1
(en)
|
1996-04-03 |
1999-01-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US6391872B1
(en)
|
1997-11-04 |
2002-05-21 |
Pfizer Inc |
Indazole bioisostere replacement of catechol in therapeutically active compounds
|
|
US6716978B2
(en)
|
1997-11-04 |
2004-04-06 |
Pfizer Inc |
Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors
|
|
EP1046631A1
(en)
|
1999-04-19 |
2000-10-25 |
Rolic AG |
Liquid crystalline compounds
|
|
GB9908934D0
(en)
|
1999-04-19 |
1999-06-16 |
Rolic Ag |
Liquid crystalline compounds
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
AU2002255263B2
(en)
|
2001-04-16 |
2006-12-14 |
Eisai R&D Management Co., Ltd. |
Novel 1H-indazole compound
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
CN1656079A
(zh)
|
2002-05-31 |
2005-08-17 |
卫材株式会社 |
吡唑化合物和含有该化合物的药物组合物
|
|
BR0313396A
(pt)
|
2002-08-12 |
2005-06-28 |
Sugen Inc |
3-pirrolil-piridopirazóis e 3-pirrolil-indazóis, como inibidores de quinase
|
|
EP1628666B1
(en)
|
2003-05-14 |
2015-09-23 |
NeuroGenetic Pharmaceuticals, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
|
WO2005040157A2
(en)
|
2003-10-22 |
2005-05-06 |
Eli Lilly And Company |
Novel mch receptor antagonists
|
|
US20050203151A1
(en)
|
2003-12-19 |
2005-09-15 |
Kalypsys, Inc. |
Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions
|
|
US7880002B2
(en)
|
2004-12-29 |
2011-02-01 |
Millennium Pharmaceuticals, Inc. |
Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
|
|
WO2006071958A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
US7834036B2
(en)
|
2005-03-04 |
2010-11-16 |
Merck Sharp & Dohme Corp |
Fused-aromatic compounds having anti-diabetic activity
|
|
WO2007044085A2
(en)
|
2005-05-19 |
2007-04-19 |
Xenon Pharmaceuticals Inc. |
Heteroaryl compounds and their uses as therapeutic agents
|
|
WO2007050124A1
(en)
|
2005-05-19 |
2007-05-03 |
Xenon Pharmaceuticals Inc. |
Fused piperidine derivatives and their uses as therapeutic agents
|
|
WO2007058626A1
(en)
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
|
CN101437519A
(zh)
|
2006-03-31 |
2009-05-20 |
艾博特公司 |
吲唑化合物
|
|
DE102006030479A1
(de)
|
2006-07-01 |
2008-03-20 |
Merck Patent Gmbh |
Indazolderivate
|
|
US20080027052A1
(en)
|
2006-07-10 |
2008-01-31 |
Sharon Moe |
Methods for treating cystic kidney disease
|
|
JP2010511382A
(ja)
|
2006-12-01 |
2010-04-15 |
エージェンシー フォー サイエンス，テクノロジー アンド リサーチ |
癌関連タンパク質キナーゼ
|
|
EP2134683A2
(en)
|
2007-02-12 |
2009-12-23 |
Intermune, Inc. |
Novel inhibitors hepatitis c virus replication
|
|
KR20100017359A
(ko)
|
2007-04-25 |
2010-02-16 |
엑셀리시스, 인코포레이티드 |
카제인 키나제 ⅱ （ｃｋ２）조절제로서의 피리미디논
|
|
AU2008248186B2
(en)
|
2007-05-07 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Method of treatment using fused aromatic compounds having anti-diabetic activity
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
JP2010111624A
(ja)
|
2008-11-06 |
2010-05-20 |
Shionogi & Co Ltd |
Ｔｔｋ阻害作用を有するインダゾール誘導体
|
|
BRPI0922364A2
(pt)
|
2008-12-03 |
2017-08-29 |
Presidio Pharmaceuticals Inc |
Composto, composição farmacêutica e uso de um composto
|
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
JP2012513399A
(ja)
|
2008-12-22 |
2012-06-14 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
WO2010088518A2
(en)
|
2009-01-31 |
2010-08-05 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
|
EP2398474A4
(en)
|
2009-02-23 |
2012-12-05 |
Presidio Pharmaceuticals Inc |
HCV NS5A SHEMMER
|
|
US8455516B2
(en)
|
2010-01-15 |
2013-06-04 |
Touro University |
HIV-1 fusion inhibitors and methods
|
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
|
EP2368876A1
(en)
|
2010-03-01 |
2011-09-28 |
Sanofi |
Derivatives of aminoindanes, their preparation and their application in therapeutics
|
|
WO2011109551A2
(en)
|
2010-03-03 |
2011-09-09 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
|
JP5763937B2
(ja)
|
2010-03-10 |
2015-08-12 |
Ａｇｃセイミケミカル株式会社 |
液晶化合物、その製造方法、液晶組成物および液晶電気光学素子
|
|
SG185515A1
(en)
|
2010-05-13 |
2012-12-28 |
Amgen Inc |
Nitrogen heterocyclic compounds useful as pde10 inhibitors
|
|
CA2806341C
(en)
|
2010-07-29 |
2020-03-24 |
Rigel Pharmaceuticals, Inc. |
Ampk-activating heterocyclic compounds and methods for using the same
|
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
|
WO2012068589A2
(en)
|
2010-11-19 |
2012-05-24 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2012092471A2
(en)
|
2010-12-29 |
2012-07-05 |
Development Center For Biotechnology |
Novel tubulin inhibitors and methods of using the same
|
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
WO2012160015A1
(en)
|
2011-05-23 |
2012-11-29 |
Sanofi |
Process for the preparation of deuterated compounds containing n-alkyl groups
|
|
CN102243505B
(zh)
|
2011-07-07 |
2013-08-14 |
矽力杰半导体技术(杭州)有限公司 |
一种低失调、快速响应的电压控制电流源、控制方法以及应用其的电源电路
|
|
JP6036693B2
(ja)
|
2011-08-05 |
2016-11-30 |
アステラス製薬株式会社 |
新規ｆｇｆｒ４変異体の検出法
|
|
AU2012296662A1
(en)
|
2011-08-15 |
2014-03-27 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
|
EP2763990B1
(en)
|
2011-09-01 |
2017-02-22 |
F. Hoffmann-La Roche AG |
Pyrrolopyrazine kinase inhibitors
|
|
EP3567029A1
(en)
|
2011-09-09 |
2019-11-13 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
|
GB201118656D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
US9254288B2
(en)
|
2012-05-07 |
2016-02-09 |
The Translational Genomics Research Institute |
Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof
|
|
CN103420906B
(zh)
*
|
2012-05-21 |
2015-09-09 |
南京圣和药业股份有限公司 |
新型酪氨酸蛋白激酶抑制剂
|
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
|
HK1214831A1
(zh)
|
2012-11-05 |
2016-08-05 |
Foundation Medicine, Inc. |
新型融合分子及其应用
|
|
US20140213538A1
(en)
|
2013-01-15 |
2014-07-31 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
|
US10980804B2
(en)
|
2013-01-18 |
2021-04-20 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
|
KR101648141B1
(ko)
|
2013-06-11 |
2016-08-12 |
제일모직 주식회사 |
화합물, 이를 포함하는 유기 광전자 소자 및 상기 유기 광전자 소자를 포함하는 표시장치
|
|
US10124003B2
(en)
|
2013-07-18 |
2018-11-13 |
Taiho Pharmaceutical Co., Ltd. |
Therapeutic agent for FGFR inhibitor-resistant cancer
|
|
WO2015035415A1
(en)
|
2013-09-09 |
2015-03-12 |
Nantomics, Llc |
Method of detecting suceptibility to breast cancer through mutations in the fgfr3 and tp53 genes
|
|
WO2015048547A2
(en)
|
2013-09-26 |
2015-04-02 |
Rigel Pharmaceuticals, Inc. |
Methods for using and biomarkers for ampk-activating compounds
|
|
CA2924843A1
(en)
|
2013-09-27 |
2015-04-02 |
Allergan, Inc. |
Compounds and methods for skin repair
|
|
EP3082802B1
(en)
|
2013-12-03 |
2020-02-26 |
Iomet Pharma Ltd. |
Tryptophan-2,3-dioxygenase (tdo) and/or indolamine-2,3-dioxygenase (ido) inhibitors and their use
|
|
EP3080298B1
(en)
|
2013-12-11 |
2018-10-31 |
AccuraGen Holdings Limited |
Methods for detecting rare sequence variants
|
|
ES2756175T3
(es)
|
2013-12-27 |
2020-04-27 |
Chugai Pharmaceutical Co Ltd |
Genes mutantes guardián de fgfr y fármacos que se dirigen a los mismos
|
|
WO2015103527A1
(en)
|
2014-01-06 |
2015-07-09 |
The Scripps Research Institute |
Modulators of rev-erb
|
|
EP3102705A4
(en)
|
2014-02-04 |
2017-10-25 |
Mayo Foundation for Medical Education and Research |
Method of identifying tyrosine kinase receptor rearrangements in patients
|
|
KR20160138494A
(ko)
|
2014-03-31 |
2016-12-05 |
데비오팜 인터네셔날 에스 에이 |
Fgfr 융합물
|
|
WO2015154169A1
(en)
|
2014-04-09 |
2015-10-15 |
The University Of British Columbia |
Binding function3 (bf3) site compounds as therapeutics and methods for their use
|
|
WO2015169425A1
(en)
|
2014-05-09 |
2015-11-12 |
Merck Patent Gmbh |
Liquid-crystalline medium and high-frequency components comprising same
|
|
US10045979B2
(en)
|
2014-05-19 |
2018-08-14 |
Merial Inc. |
Anthelmintic compounds
|
|
US10100042B2
(en)
|
2014-08-08 |
2018-10-16 |
Merck Sharp & Dohme Corp. |
[5,6]—fused bicyclic antidiabetic compounds
|
|
JP2017529332A
(ja)
|
2014-08-28 |
2017-10-05 |
オンコエシックス ゲーエムベーハー |
チエノトリアゾロジアゼピン化合物を含む医薬組成物を用いる急性骨髄性白血病又は急性リンパ性白血病の治療方法
|
|
KR20170082590A
(ko)
|
2014-11-11 |
2017-07-14 |
메르크 파텐트 게엠베하 |
바이메소젠성 화합물 및 메소젠성 매질
|
|
JP2018027019A
(ja)
|
2014-11-26 |
2018-02-22 |
国立研究開発法人国立がん研究センター |
胆道がんにおける新規治療標的融合遺伝子
|
|
EP3237638B1
(en)
|
2014-12-24 |
2020-01-15 |
F.Hoffmann-La Roche Ag |
Therapeutic, diagnostic and prognostic methods for cancer of the bladder
|
|
US20180237424A1
(en)
|
2015-03-03 |
2018-08-23 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Fgfr3 antagonists
|
|
KR101663277B1
(ko)
|
2015-03-30 |
2016-10-06 |
주식회사 녹십자 |
TNIK, IKKε 및 TBK1 억제제로서의 피라졸계 유도체 및 이를 포함하는 약학적 조성물
|
|
US11040976B2
(en)
|
2015-04-24 |
2021-06-22 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (IDE) and uses thereof
|
|
CN106317023A
(zh)
|
2015-07-10 |
2017-01-11 |
中国科学院上海药物研究所 |
吲唑类化合物的制备方法和用途
|
|
WO2017024968A1
(zh)
|
2015-08-07 |
2017-02-16 |
南京明德新药研发股份有限公司 |
作为fgfr和vegfr抑制剂的乙烯基化合物
|
|
CA3001857A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
MX2018004879A
(es)
|
2015-10-22 |
2019-02-28 |
Selvita S A |
Nuevos derivados de piridona y su uso como inhibidores de quinasas.
|
|
EP3424702A4
(en)
|
2016-03-02 |
2019-10-23 |
JNC Corporation |
LAMINATE, ELECTRONIC DEVICE AND MANUFACTURING METHOD FOR LAMINATE
|
|
WO2017150587A1
(ja)
|
2016-03-02 |
2017-09-08 |
Jnc株式会社 |
低熱膨張部材用組成物、低熱膨張部材、電子機器、低熱膨張部材の製造方法
|
|
BR112018068703B1
(pt)
|
2016-03-16 |
2024-02-06 |
Kura Oncology, Inc. |
Inibidores substituídos de menin-mll e métodos de uso
|
|
US20190177617A1
(en)
|
2016-05-12 |
2019-06-13 |
Merck Patent Gmbh |
Bimesogenic compounds and mesogenic media
|
|
US11124628B2
(en)
|
2016-08-30 |
2021-09-21 |
Dow Global Technologies Llc |
Method of attenuating concerntration of acrolein
|
|
JP6589795B2
(ja)
|
2016-09-27 |
2019-10-16 |
信越化学工業株式会社 |
スルホニウム塩、レジスト組成物及びパターン形成方法
|
|
WO2018226976A1
(en)
|
2017-06-08 |
2018-12-13 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
|
WO2019018795A1
(en)
|
2017-07-20 |
2019-01-24 |
Yumanity Therapeutics |
COMPOUNDS AND USES THEREOF
|
|
US11787766B2
(en)
|
2017-08-18 |
2023-10-17 |
Shanghai Ennovabio Pharmaceuticals Co., Ltd. |
Compound having PD-L1 inhibitory activity, preparation method therefor and use thereof
|
|
US11795162B2
(en)
|
2017-08-18 |
2023-10-24 |
Saint Louis University |
Modulators of the estrogen-related receptor
|
|
WO2019209948A1
(en)
|
2018-04-25 |
2019-10-31 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
WO2020051207A2
(en)
|
2018-09-04 |
2020-03-12 |
Magenta Therapeutics Inc. |
Aryl hydrocarbon receptor antagonists and methods of use
|
|
KR102127006B1
(ko)
|
2018-12-06 |
2020-06-25 |
한국생산기술연구원 |
피리미딘계 작용기 함유 단분자 화합물, 상기 화합물의 광가교물을 포함한 유기물층 및 이를 포함하는 유기전자소자
|
|
CA3124970A1
(en)
|
2018-12-28 |
2020-07-02 |
Cedars-Sinai Medical Center |
Methods of treating inflammatory bowel diseases that target ripk2
|
|
CN111434655A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
溶血磷脂酸受体拮抗剂及其制备方法
|
|
IN201941011265A
(enExample)
*
|
2019-03-22 |
2020-09-25 |
|
|
|
WO2020228756A1
(zh)
|
2019-05-14 |
2020-11-19 |
上海翰森生物医药科技有限公司 |
含二并环类衍生物抑制剂、其制备方法和应用
|
|
WO2021007269A1
(en)
|
2019-07-09 |
2021-01-14 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
CN112409331B
(zh)
|
2019-08-21 |
2024-02-20 |
上海翰森生物医药科技有限公司 |
杂环类衍生物抑制剂、其制备方法和应用
|
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
GEAP202415945A
(en)
|
2019-10-14 |
2024-04-25 |
Incyte Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
CN112812014B
(zh)
|
2019-11-15 |
2024-05-10 |
石家庄诚志永华显示材料有限公司 |
化合物、液晶组合物、液晶显示器
|
|
CN113179640B
(zh)
|
2019-11-26 |
2024-06-25 |
上海翰森生物医药科技有限公司 |
含氮多环类衍生物抑制剂、其制备方法和应用
|
|
TW202136253A
(zh)
|
2019-12-19 |
2021-10-01 |
美商卡司馬療法公司 |
Ｔｒｐｍｌ調節劑
|
|
US12441707B2
(en)
|
2019-12-30 |
2025-10-14 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
US20230128972A1
(en)
|
2020-01-31 |
2023-04-27 |
Atomwise Inc. |
Anat Inhibitors and Methods of Use Thereof
|
|
KR20220141328A
(ko)
|
2020-02-12 |
2022-10-19 |
큐라데브 파마 프라이버트 리미티드 |
소분자 sting 길항제
|
|
WO2021178780A1
(en)
|
2020-03-06 |
2021-09-10 |
ESCAPE Bio, Inc. |
Indazoles and azaindazoles as lrrk2 inhibitors
|
|
WO2021183970A1
(en)
|
2020-03-13 |
2021-09-16 |
University Of Maryland, Baltimore |
Non-atp/catalytic site p38 mitogen activated protein kinase inhibitors
|
|
MX2022013861A
(es)
|
2020-05-06 |
2023-02-22 |
Servier Lab |
Nuevos inhibidores macrociclicos de la quinasa de lrrk2.
|
|
MX2023007793A
(es)
|
2020-12-30 |
2023-09-22 |
Tyra Biosciences Inc |
Compuestos de indazol como inhibidores de cinasas.
|
|
JP2024512449A
(ja)
|
2021-03-18 |
2024-03-19 |
レ ラボラトワール セルヴィエ |
大環状ｌｒｒｋ２キナーゼ阻害剤
|
|
CR20230449A
(es)
|
2021-03-19 |
2023-11-23 |
Arvinas Operations Inc |
Compuestos a base de indazol y métodos de uso asociados
|
|
US20240316022A1
(en)
*
|
2021-06-30 |
2024-09-26 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
CA3247536A1
(en)
|
2022-04-04 |
2023-10-12 |
Brenig Therapeutics, Inc. |
LEUCINE-RICH KINASE 2 REPETITION INHIBITORS
|
|
EP4547670A1
(en)
|
2022-06-29 |
2025-05-07 |
Tyra Biosciences, Inc. |
Polymorphic compounds and uses thereof
|
|
TW202416961A
(zh)
|
2022-06-29 |
2024-05-01 |
美商泰拉生物科學公司 |
吲唑化合物
|
|
JP2025529161A
(ja)
|
2022-08-30 |
2025-09-04 |
タイラ・バイオサイエンシーズ・インコーポレイテッド |
活性化ｆｇｆｒ３遺伝子変化を有する固形腫瘍を処置する方法
|